hormonal therapy

Ridoxia Tablet 160 mg contains Megestrol Acetate 160 mg, a synthetic progestin primarily prescribed to stimulate appetite and promote weight gain in patients experiencing significant weight loss due to chronic illnesses. It is also used in the treatment of certain hormone-sensitive cancers, including advanced breast cancer and endometrial (uterine) cancer, as directed by an oncologist. Megestrol acetate works by influencing hormone receptors and helping improve appetite, calorie intake, and body weight in eligible patients. In oncology, it may also help slow the growth of certain cancer cells that are responsive to hormonal therapy. Ridoxia Tablet should be taken exactly as prescribed by a qualified healthcare professional. The dosage and duration of treatment depend on the patient's medical condition, treatment goals, and response to therapy. Regular follow-up is important to monitor effectiveness and manage any potential side effects. Key Features Contains Megestrol Acetate 160 mg Used for appetite stimulation and management of significant weight loss in appropriate patients Also indicated for certain hormone-sensitive cancers under specialist supervision Oral tablet for convenient administration Prescription medicine requiring medical supervision Manufactured under quality-controlled pharmaceutical standards Note: Ridoxia Tablet should only be used under the guidance of a healthcare professional. It is not suitable for self-medication, and patients should follow their physician's instructions regarding dosage, duration, and monitoring.